Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses

The mucopolysaccharidoses (MPS) are a group of 11 lysosomal storage diseases (LSDs) produced by mutations in the enzymes involved in the lysosomal catabolism of glycosaminoglycans. Most of the mutations affecting these enzymes may lead to changes in processing, folding, glycosylation, pH stability,...

Descripción completa

Detalles Bibliográficos
Autores principales: Losada Díaz, Juan Camilo, Cepeda del Castillo, Jacobo, Rodriguez-López, Edwin Alexander, Alméciga-Díaz, Carlos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981736/
https://www.ncbi.nlm.nih.gov/pubmed/31905715
http://dx.doi.org/10.3390/ijms21010232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981736/
https://www.ncbi.nlm.nih.gov/pubmed/31905715
http://dx.doi.org/10.3390/ijms21010232

Ejemplares similares